Apellis Pharmaceuticals Inc. News
Cramer's Mad Money Recap 10/6: Dow, General Motors
Jim Cramer says it's hard to explain why stocks opened lower, but he thinks investors should have some conviction and look for buying opportunities.
5 Top Stock Gainers for Monday: Discovery, Apellis Pharma
Apellis Pharmaceuticals, Harley-Davidson, Dillard's, Children's Place and Harmony Gold are five top gainers for Monday.
Apellis Jumps on Blood Disease Treatment Approval
Apellis says the U.S. Food & Drug Administration has approved its Empaveli treatment for a rare blood disease.
Editas Medicine Falls as Goldman Sachs Initiates the Stock at Sell
Editas is initiated with a sell rating and $20 price target at Goldman Sachs.
Resilient Bull: Cramer's 'Mad Money' Recap (Wednesday 1/8/20)
Jim Cramer says this market environment is a strange merger of resilience, complacency and hubris. He explains how this feeds a stock rally.
Apellis Pharmaceuticals Soars on Blood-Drug Test
Apellis' treatment for PNH, a rare blood disease, outperforms Alexion's Soliris, the company says.
Apellis Pharma Climbs on Upgrade to Overweight at JP Morgan
JP Morgan analysts see promising opportunities in Apellis's later-stage drug to treat the blood disorder PNH.
Breaking News
Trevor Noah Has Many Potential Replacements at 'The Daily Show'
But Comedy Central could also do something really unexpected with its former flagship program.
Musk Reveals New Cybertruck Features That Will Amaze EV Buyers
Tesla is expected to start production of its highly anticipated futuristic truck in 2023.
Disney Gives Beloved Character a Starring Movie Role
A development team led by Seth Rogen is working on a production that centers on a less well-known character with a nonetheless devoted following.
Fed Inflation Gauge Speeds Higher In August, Adding To Rate Hike Bets
The Fed's preferred inflation gauge topped Street forecasts Friday, snuffing out hopes of a near-term change in the central bank's rate hiking plans.